Tag: vaccine

NIH begins clinical trial of live, attenuated Zika vaccine

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll a total of 28 healthy, non-pregnant adults ages 18 to 50 at the Johns Hopkins Bloomberg

Promoting HPV Vaccine Doesn’t Prompt Risky Sex by Teens: Study

MONDAY, Aug. 13, 2018 — Controversial state laws that promote vaccinating kids against the human papillomavirus (HPV) do not increase the likelihood that teens will engage in risky sexual behavior, a new study contends. “Parents and caregivers, as well as policy makers, should not be wary of policies or legislation related to HPV education or

WHO reports new Ebola case in DR Congo, vaccine this week

The head of the World Health Organization said Sunday there has been another reported case of Ebola in the Democratic Republic of Congo and that an experimental vaccine to fight the disease is expected to become available in the country this week. Doctor Tedros Adhanom Ghebreyesus, on a two-visit to DR Congo, said the suspected

New vaccine could help people overcome bath salts abuse

Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones, or bath salts. The vaccine blunts the illegal stimulant’s effects on the brain, which could help recovering drug users who experience a relapse. Samantha McClenahan, a doctoral student at the University of Arkansas for Medical Sciences, will present test results

Study predicts 2018 flu vaccine will have 20 percent efficacy

A Rice University study predicts that this fall’s flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the vaccine given in 2016 and 2017 due to viral mutations related to vaccine production in eggs. The Rice method, known

WHO recommends use of first typhoid conjugate vaccine

The World Health Organization (WHO) recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries. This new policy will help ensure access to typhoid vaccination in communities most impacted by the disease, which is responsible for nearly 12 million infections and between 128,000 and 161,000